atepeq/tico19 huggingface dataset:
All features of the novel SARS-CoV-2 virus occur in related coronaviruses in nature.
Jidhka bilaa aadanka banaankiisa, fayrusku waxaa lagu dilaa saabuunta guriga lagu isticmaalo, taas oo ka qarxisa lakabka ilaalinaya. SARS-CoV-2 waxa uu si dhaw ula xidhiidhaa SARS-CoV.
Outside the human body, the virus is killed by household soap, which bursts its protective bubble.SARS-CoV-2 is closely related to the original SARS-CoV.
Sanbabku waa unuga ugu badan ee uu saameeyo COVID-19 maadaama oo fayrusku uu ka geli karo unuga enzyme angiotensin-oo uu u badalo enzyme 2 (ACE2), kaas oo ku badan nooca II alveolar unuga ah ee sanbabka.
The lungs are the organs most affected by COVID-19 because the virus accesses host cells via the enzyme angiotensin-converting enzyme 2 (ACE2), which is most abundant in the type II alveolar cells of the lungs.
Fayrusku waxa uu isticmaalaa meelaha sare glycoprotein oo loo yaqaan "korodh" (peplomer) si uu ugu xidhmo ACE2 iyo unuga qaabila oo dhan.
The virus uses a special surface glycoprotein called a "spike" (peplomer) to connect to ACE2 and enter the host cell.
Dhaawaca daran ee wadnaha waxaa lagu arkaa 12% dadka uu ku dhacay ee la dhigay isbitaalka Wuhan, Jayna, oo waxaana uu aad ugu badan yahay xanuunka aadka u daran.
Acute cardiac injury was found in 12% of infected people admitted in hospital in Wuhan, China, and is more frequent in severe disease.
Xadiga xanuunka wadna ayaa ku badan, taas oo keena in uu olol yimaado jawaab celin ah oo uu khalkhalo nidaamka difaacu inta uu socdo, laakiin dhaawaca myocardial ee daran waxa uu sidoo kale la xidhiidhi karaa ACE2 qaadaha wadnaha.
Rates of cardiovascular symptoms is high, owing to the systemic inflammatory response and immune system disorders during disease progression, but acute myocardial injury may also be related to ACE2 receptors in the heart.
Qaadaha ACE2 waxa aad loogu arkaa wadnaha oo waxaa kamid ah inuu wadnuhu shaqada joojiyo.
ACE2 receptors are highly expressed in the heart and are involved in heart function.
Korodh imaatinta thrombosis (31%) iyo venous thromboembolis (25%) ayaa lagu arkay bukaanka ICU ee qaba xanuunka COVID-19 oo waxa uuna la xidhiidhi karaa caafimaadkooda liita. Shaybaadhka wax ku ool ah ee lagu sameeyay dadka u dhintay COVID-19 waxaa lagu ogaaday inuu waxyeelay alveolar (DAD), iyo oo lymphocyte uu ku jiro gubasho filter garayn ah ee sanbabka.
A high incidence of thrombosis (31%) and venous thromboembolism (25%) have been found in ICU patients with COVID-19 infections and may be related to poor prognosis.Autopsies of people who died of COVID-19 have found diffuse alveolar damage (DAD), and lymphocyte-containing inflammatory infiltrates within the lung.
Inkasta oo SARS-COV-2 uu leeyahay tropism ACE2-sheegitaanka unuga epithelial ee la socodka neefsiga, bukaanka qaba COVID-19 aad u daran calaamadaha ah ee nidaamka kacsanaanta ololka.
Although SARS-COV-2 has a tropism for ACE2-expressing epithelial cells of the respiratory tract, patients with severe COVID-19 have symptoms of systemic hyperinflammation.
Gaar ahaan, xanuunka GM-CSF-ee daloolinaya unugyada-T waxa lagu arkay in ay xidhiidhaan imaatinta ololka IL-6 ee gelinta iyo adkaanshaha xanuunka sanbabka ee bukaanka COVID-19.
In particular, pathogenic GM-CSF-secreting T-cells were shown to correlate with the recruitment of inflammatory IL-6-secreting monocytes and severe lung pathology in COVID-19 patients.
Ololka lymphocytic waxa sidoo kale lagu ogaaday shaybaadhka maydka.
Lymphocytic infiltrates have also been reported at autopsy.
WHO waxay baahisay dhawr shaybaadh oo lagu sameeyay xanuunka.
The WHO has published several testing protocols for the disease.
Qaabka rasmiga ah ee shaybaadhka waxaa weeye in markaa la badalo qoraalka polymerase ee jawaab celinta (rRT-PCR).
The standard method of testing is real-time reverse transcription polymerase chain reaction (rRT-PCR).
Shaybaadhka waxaa kaliya lagu sameeyaa muunada duufka ee markaa lagu qaaday burushka sanka la geliyay; laakiin, muunada duufka ama xaakadu waxa ayaa sidoo kale la isticmaali karaa.
The test is typically done on respiratory samples obtained by a nasopharyngeal swab; however, a nasal swab or sputum sample may also be used.
Natiijada ayaa caadiyan lagu helaa dhawr saacadood ilaa laba maalmood.
Results are generally available within a few hours to two days.
Dhiiga ayaa sidoo kale la isticmaali karaa, laakiin waxa uu u baahan doonaa lama muunadood oo dhiig ah oo la qaado laba todobaad wakhti ku dhaxeeya oo natiijadana waxa uu noqonayaa waxoogaa dhaxaad.
Blood tests can be used, but these require two blood samples taken two weeks apart and the results have little immediate value.
Saynisyahano jayniis ah ayaa gooni u saaray unuga coronavirus oo waxa ay baahiyeen hide sidihiisa si shaybaadhada caalamku ay si iskood ah ugu samayn karaan jawaab celin (PCR) shaybaadh ah oo lagu onaadao caabuqa fayruska.
Chinese scientists were able to isolate a strain of the coronavirus and publish the genetic sequence so laboratories across the world could independently develop polymerase chain reaction (PCR) tests to detect infection by the virus.
Abriil 4, 2020, shaybaadh antiboodhiga ah (kaas oo lagu ogaanayo caabuqa firfircoon iyo hadii qofku uu hore usoo qaaday) ayaa la sameeyay, laakiin weli si baahsan looma isticmaalin.
As of 4 April 2020, antibody tests (which may detect active infections and whether a person had been infected in the past) were in development, but not yet widely used.
Tijaabo Jayniis ah oo shaybaadhka ah ayaa lagu muujiyay inuu saxan yahay 60 ilaa 70%.
The Chinese experience with testing has shown the accuracy is only 60 to 70%.
FDA Maraykanka ayaa ansixiyay shaybaadhka meesha kowaad ee daryeelka 21 Maarso 2020 ee isticmaalka dhamaadka bisha. Tilmaamaha shaybaadhka ayay baahiyeen Isbitaalka Zhongnan ee Jaamacada Wihan qaabka ay talisay ee lagu ogaanayo ee markaa ku salaysan qaabka tijaabada caafimaad ee khatarta safmarka.
The FDA in the United States approved the first point-of-care test on 21 March 2020 for use at the end of that month.Diagnostic guidelines released by Zhongnan Hospital of Wuhan University suggested methods for detecting infections based upon clinical features and epidemiological risk.
Dhawr tibolaar laba dhinac ah oo muraag hoose ah oo opacities oo leh periphral, asymmetric posterior oo si baahsan loogu qaybiyo ayaa ah ka ugu caamsan.
Bilateral multilobar ground-glass opacities with a peripheral, asymmetric and posterior distribution are common in early infection.
Subpleural badnaantiisa, samayska daran (lobular septal cufka ah ee kala duwanaanshaha), iyo isku dhaga ayaa noqon kara socod xanuunka ah.
Subpleural dominance, crazy paving (lobular septal thickening with variable alveolar filling), and consolidation may appear as the disease progresses.
Macluumaad yar ayaa laga heleyaa diirada waynaysada iyo xanuunka COVID-19.
Few data are available about microscopic lesions and the pathophysiology of COVID-19.
Xanuunka ugu wayn ee lagu ogaaday shaybaadhka maydku waa:
The main pathological findings at autopsy are:
Mascroscopy: pleurisy, pericarditis, isku keenista sanbabka iyo oedema baabacada
Macroscopy: pleurisy, pericarditis, lung consolidation and pulmonary oedema
Afar nooc oo kuwa aadka u daran ah ee noocda fayruska ayaa la arki karayay:
Four types of severity of viral pneumonia can be observed:
waxoogaa xanuunka sanbabka: pulmonarty oedema, xanuunka sababka ee pneumocyte, noocyo balaadhan oo xanuunka sababka ah, olol xiidmaha ah oo leh soco lymphocytic iyo multinucleated ka yimid qaab samayska unuga.
mild pneumonia: pulmonary oedema, pneumocyte hyperplasia, large atypical pneumocytes, interstitial inflammation with lymphocytic infiltration and multinucleated giant cell formation
xanuunka sanbabka ee daran: waxyeelada alveolar (DAD) ee gelitaanka alveolar ayaa laga reebey.
severe pneumonia: diffuse alveolar damage (DAD) with diffuse alveolar exudates.
DAD waxa uu keenaa mushkilad dhanka neefsiga ah oo daran (ARDS) iyo hypoxemia.
DAD is the cause of acute respiratory distress syndrome (ARDS) and severe hypoxemia.
xanuunada sanbabka kulaylka: waxa ay sameeyaan ka saarida carjawada alveolar iyo xiidmaha snababka
healing pneumonia: organisation of exudates in alveolar cavities and pulmonary interstitial fibrosis
Dhiiga: qaybin murqaha ah oo xidhan (DIC); jawaab celin leukoerythroblastic
Blood: disseminated intravascular coagulation (DIC); leukoerythroblastic reaction
Talaabooyinka lagu yaraynayo qaadida caabuqa waxa kamid ah joogitaanka gurgia, in la iska ilaaliyo meelaha dadku iskugu yimaadaan, in gacmaha la gu farxasho saabuun iyo biyo badanaa iyo in ugu yaraan 20 ilbidhiqsi la isku xoqo, in la ilaaliyo nadaafada neefsiga iyo in la iska ilaaliyo taabashada indhaha, sanka, ama afka iyada oo aan la farxalan.
Preventive measures to reduce the chances of infection include staying at home, avoiding crowded places, washing hands with soap and water often and for at least 20 seconds, practising good respiratory hygiene and avoiding touching the eyes, nose or mouth with unwashed hands.
CDC waxay ku talinaysaa in la saarto afka iyo sanka kilinikis marka la qufacayo ama hundhisayo oo waxay ku talinayaan in la isticmaalo suxulka gudaha hadii aan la haysan kilinikis.
The CDC recommends covering the mouth and nose with a tissue when coughing or sneezing and recommends using the inside of the elbow if no tissue is available.
Farxalka sax ah kadib marka la qufaco ama hindhiso.
Proper hand hygiene after any cough or sneeze is encouraged.
CDC waxay ku talinaysaa in la isticmaalo maro nadiif ah oo wajiga lagu xidho meelaha banaanka ah marka loosoo baxo, si loo yareeyo isku gudbinta asxaamaha shakhsi ahaaneed. Kala fogaanshaha waxaa loogu talo geley in lagu yareeyo isku gudbinta dadka iyada oo badan isku yimaada meelaha dugsiyada iyo shaqada, xadidaada socdaalka iyo joojinta isku imaatinka dadka badan.
The CDC has recommended the use of cloth face coverings in public settings, in part to limit transmission by asymptomatic individuals.Social distancing strategies aim to reduce contact of infected persons with large groups by closing schools and workplaces, restricting travel and cancelling large public gatherings.
Tilmaamaha kala fogaanshaha waxaa kamid ah in dadku ay isku jirsadaan 6 fuudh (1.8 mitir) in ah.
Distancing guidelines also include that people stay at least 6 feet (1.8 m) apart.
Ma jirto dawo la garnaayo ee lagaga hortago COVID-19. Talaalkana lama filanyo inuu soo baxo ilaa horaanta 2021, qayb muhiim ah oo lagu maamuliya COVID-19 waa in la yareeyo kor u kaca faafista, oo loo yaqaan "yaraynta socodka".
There is no medication known to be effective at preventing COVID-19.As a vaccine is not expected until 2021 at the earliest, a key part of managing COVID-19 is trying to decrease the epidemic peak, known as "flattening the curve".
CDC waxay ku talinaysaa in badanaa lagu farxasho sabuun iyo biyo ugu yaraan 20 ilbidhiqsi, gaar ahaan marka suuliga lagasoo baxo ama gacmuhu ay uskag yihiin oo ay muuqdaan, kahor inta aan cunto la cubin iyo kadib marka duufka la iska fi'iyo, qudaco ama hundhiso.
The CDC also recommends that individuals wash hands often with soap and water for at least 20 seconds, especially after going to the toilet or when hands are visibly dirty, before eating and after blowing one's nose, coughing or sneezing.
Sidoo kale waxaa lagu taliyaa in la isticmaalo gacmo nadiifiyaha alkohoosha leh oo ugu yaraan 60% alkohool ah, laakiin kaliya marka aan la heleynin sabuun iyo biyo. Meelaha aan lagu iibin gacmo nadiifiyaha, WHO waxay bixisaa talaabo loogu samaysanayo sidaada.
It further recommends using an alcohol-based hand sanitiser with at least 60% alcohol, but only when soap and water are not readily available.For areas where commercial hand sanitisers are not readily available, the WHO provides two formulations for local production.
Qaacidadan, hawsha antimikrobaatku waxa ka yimaada ethanol ama isopropanol.
In these formulations, the antimicrobial activity arises from ethanol or isopropanol.
Hydrogen peroxide ayaa loo isticaalaa si meesha looga saaro kacsanaanta baakteeriyada ee alkohoosha; "maaha shay firfircoon".
Hydrogen peroxide is used to help eliminate bacterial spores in the alcohol; it is "not an active substance for hand antisepsis".
Glycerol waxaa lagu daraa humectant.
Glycerol is added as a humectant.
Dadka waxaa lagu maamulaa daryeel la kormeeray, kaas oo ay ku jiraan daawaynta dheecaanada, taageero ogsajiin, iyo taageerida unugyada kale ee uu fayrusku saameeyay.
People are managed with supportive care, which may include fluid therapy, oxygen support, and supporting other affected vital organs.
CDC waxay ku talinaysaa in dadka looga shakiyo inay sidaan fayruska ay xidhaan waji gashad.
The CDC recommends that those who suspect they carry the virus wear a simple face mask.
Ogsajiinta xabka extracororeal (ECMO) waxa loo isticmaalahaa sidii looga jawaabi lahaa mushkilada neefsiga, laakiin faa'idadeeda wali waa la eegayaa.
Extracorporeal membrane oxygenation (ECMO) has been used to address the issue of respiratory failure, but its benefits are still under consideration.
Nadaafada shakhsi ahaaneed iyo qaab nololeedka caafimaadka iyo nafaqada ayaa la sheegaa inay kor u qaadaan difaaca.
Personal hygiene and a healthy lifestyle and diet have been recommended to improve immunity.
Daawaynta taageerada ah waxay wax u tari kartaa dadka leh calaamadaha yar wakhtiga hroe ee uu xanuunku ku dhaco. WHO iyo Gudida Caafimaadka Qaran ee Jayniiska waxa ay baahiyeen talooyin lagu. ilaalinayo dadka la dhigay isbitaalka ee qaba COVID-19.
Supportive treatments may be useful in those with mild symptoms at the early stage of infection.The WHO and Chinese National Health Commission have published recommendations for taking care of people who are hospitalised with COVID-19.
Dhakhaatiirta xiidmaha iyo sanbabka ayaa isku daray daawaynta Marayknaka ee lagu taliyo oo kala heley hay'adp kala duwan oo waxay ka dhigeen khayraad bilaash ah, IBCC.
Intensivists and pulmonologists in the U.S. have compiled treatment recommendations from various agencies into a free resource, the IBCC.
Abriil 2020, ma jirto wax daawayn ah oo cayiman oo uu leeyahay COVID-19.
As of April 2020, there is no specific treatment for COVID-19.
Calaamadaha, xirfadlayaal caafimaadka qaar ayaa ku taliya in baraasitimoosha (acetaminophen) laga doorbido ibubarafiinta marka hore.
For symptoms, some medical professionals recommend paracetamol (acetaminophen) over ibuprofen for first-line use.
Waa in laga taxadirtaa sidii loo yarayn lahaa khatarta isku gudbinta fayruska, gaar ahaan habdhismeedka daryeelka caafimaadka marka la samaynayo daawaynta keeni karta hawo la neefsado, sida intubation ama neefsiga gacmaha.
Precautions must be taken to minimise the risk of virus transmission, especially in healthcare settings when performing procedures that can generate aerosols, such as intubation or hand ventilation.
Xirfadlayaasha daryeelka caafimaad ee daryeelka dadka qaba COVID-19, CDC waxay ku talinaysaa in dadka la geliyo Qolka Aysoleeshinka Caabuqa Wada (AIIR) oo ka dheeraad ah in la sameeyo taxadirka caadiga ah, xidhiidhka dadka iyo taxadirka hawo kagalaya. CDC waxay sheegtey in tilmaamaha loo isticmaalayo agabka ilaalada shakhsi ahaaneed (PPE) inta uu jiro safmarku.
For healthcare professionals caring for people with COVID-19, the CDC recommends placing the person in an Airborne Infection Isolation Room (AIIR) in addition to using standard precautions, contact precautions and airborne precautions.The CDC outlines the guidelines for the use of personal protective equipment (PPE) during the pandemic.
Agabka lagu taliyo waa: PPE-ga dirayska, neefsiga ama waji gashad, indho ilaaliye, iyo golofiska gacmaha. Marka la heli karo, neefsiga (halka waji gashad) uu ka noqon lahaa ayaa la doorbidaa.
The recommended gear is: PPE gown, respirator or facemask, eye protection, and medical gloves.When available, respirators (instead of facemasks) are preferred.
Waji gashadka N95 ayaa loo ansixiyay shaqadan laakiin FDA waxa ay soo saartay in loo isticmaali waji gashad Ansixinta Isticmaalka Xaalada Degdeg ah (EUA).
N95 respirators are approved for industrial settings but the FDA has authorised the masks for use under an Emergency Use Authorisation (EUA).
Waxaa loogu talo geley in la iskaga ilaaliyo xanuunada hawada raaca sida dhaska laakiin waxa ay wax ka taraan wixii noole ah laakiin lama damaanad qaadi karo isticmaalka nooc kasta.
They are designed to protect from airborne particles like dust but effectiveness against a specific biological agent is not guaranteed for off-label uses.
Marka aan la heleynin waji gashadka, CDC waxay ku taliysaa in wajiga la xidho, ama, hadii wax kale la waayo, in wajigashad guriga lagu samaysto.
When masks are not available, the CDC recommends using face shields or, as a last resort, homemade masks.
Badanaa COVID-19 aad uma adka ama waxba kama badalo qaabka, laakiin waxoogaa kiisaska ayaa sidaa ah.
Most cases of COVID-19 are not severe enough to require mechanical ventilation or alternatives, but a percentage of cases are.
Noocyada taageerada neefsiga ee COVID-19 waxa uu la xidhiidhaa ku guul daraysiga neefsiga kaas oo si wanaagsan loogu daraasadaynayo dadka ku jira isbitaalka, taas oo cadaymo muujinayaan in tuunbo la is geliyo la iska ilaalin karo oo sanka la iskaga dhaadhiciyo ama laba heer oo hawo mareenka ah.
The type of respiratory support for individuals with COVID-19 related respiratory failure is being actively studied for people in hospital, with some evidence that intubation can be avoided with a high flow nasal cannula or bi-level positive airway pressure.
Hadii labadani ay isku faa'ido leeyihiin dadka xanuunsanaya iyo in kale lama garanayo.
Whether either of these two leads to the same benefit for people who are critically ill is not known.
Dhakhaatiirta qaar ayaa doorbida joogitaanka guriga qaab neefsi ah marka la heli karo maadaama oo qaabkan uu xadido faafitaanka neefsiga marka la barbardhigo dulka sanka. Mararka ay aad u daran tahay waxaa ku caan ah dadka waawaayn (dadka ka wayn 60 jirka, iyo gaar ahaan kuwa ka wayn 80 jirka).
Some doctors prefer staying with invasive mechanical ventilation when available because this technique limits the spread of aerosol particles compared to a high flow nasal cannula.Severe cases are most common in older adults (those older than 60 years, and especially those older than 80 years).
Dalal badan oo soo koraya ma laha sariiro isbitaal oo ku filan tirada dadkooda, taas oo xadida awooda nidaamka caafimaadku uu kala tacaalayo hadii uu si lama filaan ah kor ugu kacdo dirada dadka ee qaba COVID-19 aadka u daran ee markaa u baahan isbitaalka.
Many developed countries do not have enough hospital beds per capita, which limits a health system's capacity to handle a sudden spike in the number of COVID-19 cases severe enough to require hospitalisation.
Hal daraasad oo lagu sameeyay Jayna ayaa lagu ogaaday in 5% dadka ka dhigay waaxda daryeelka sare, 2.3% ay u baahdeen mishiinka taageerada neefsiga, oo 1.4% ay u dhinteen.
One study in China found 5% were admitted to intensive care units, 2.3% needed mechanical support of ventilation, and 1.4% died.
Jayna, celcelis ahaan 30% dadka isbitaalka loo dhigay COVID-19 ayaa markii danbe waaxda ICU loo gudbiyay.
In China, approximately 30% of people in hospital with COVID-19 are eventually admitted to ICU.
Mishiinka neefsiga ayaa murugsanaaday markii xanuunka neefsigu uu kordhay (ARDS) marka uu kordho COVID-19 oo ogsajiin qaadashada ayaa aad u adkaata.
Mechanical ventilation becomes more complex as acute respiratory distress syndrome (ARDS) develops in COVID-19 and oxygenation becomes increasingly difficult.
Mishiino neefsi oo awooda inay qaabka cadaadiska ah inay maamulaa iyo PEEP sare ayaa loogu baahday si heerka ugu sareeya loo gaadhsiiyo gaadhsiinta ogsajiinta si loogu yareeyo khatarta neefsiga ee la xidhiidha dhaawaca sanbabka iyo preumothorax.
Ventilators capable of pressure control modes and high PEEP are needed to maximise oxygen delivery while minimising the risk of ventilator-associated lung injury and pneumothorax.
PEEP-ka sare malaha mishiinada neefsiga ah ee hore.
High PEEP may not be available on older ventilators.
Daraasad ayaa muujinaysa in daawayntu ay ka bilaabmayso Janaayo 2020, oo dawooyinka fayruska caafimaad ahaan la tijaabin doono.
Research into potential treatments started in January 2020, and several antiviral drugs are in clinical trials.
Remdesivir ayaad moodaa inay tahay ta ugu faa'idada badan.
Remdesivir appears to be the most promising.
In kasta oo dawooyinka cusub ay qaadan kartaan ilaa 2021 samayntoodu, dhawr kamid ah dawooyinkan ayaa la tijaabiyay oo hore loo ansixiyay si waxyaabo kale loogu isticmaalo ama marka hore heer sare maraya.
Although new medications may take until 2021 to develop, several of the medications being tested are already approved for other uses or are already in advanced testing.
Dawooyinka fayruska ayaa lagu tijaabin karaa dadka xanuunada daran qaba.
Antiviral medication may be tried in people with severe disease.
WHO waxay sheegtay in dadka iskoodh isku xilqaada ay ka qayb qaadanayaan tijaabada wax ku oolnimada iyo amaanka daawaynta mustaqbalka. FDA waxay bixisay ogolaansho kumeel gaadh ah oo convalescent plasma-ha ah kaas oo ah daawayn tijaabo ah oo marka ay xaalada qofku aad u daran tahay ama uu u baahan yahay daawayn dhakhso ah.
The WHO recommended volunteers take part in trials of the effectiveness and safety of potential treatments.The FDA has granted temporary authorisation to convalescent plasma as an experimental treatment in cases where the person's life is seriously or immediately threatened.
Weli lama samaynin tijaabo caafimaad oo muujinaysa maanka iyo waxtarka ay u leedahay xanuunka.
It has not undergone the clinical studies needed to show it is safe and effective for the disease.
Febraayo 2020, Jayna waxay samaysay app lagaga shaqaynayo safmarka xanuunka.
In February 2020, China launched a mobile app to deal with the disease outbreak.
Dadka isticmaalaya waxaa laga dalbanayaa inay gelitaan magaca iyo lambarka aqoonsiga.
Users are asked to enter their name and ID number.
App-ku waxa uu awoodaa inuu la socdo 'dadka isku dhawaada' isaga oo adeegsanaya macluumaadka kormeerka iyo khatarta isqaadsiinta iman karta.
The app is able to detect 'close contact' using surveillance data and therefore a potential risk of infection.
Isticmaale kastaa waxa uu eegi karaa sidoo kale xaalada sadex isticmaale oo kale.
Every user can also check the status of three other users.
Hadii la ogaado khatar iman karta, app-ku kaliya kuma talinayo in meel la isku soo xidho, waxa uu sidoo kale wargelinayaa saraakiisha maamulka deegaanka. Macluumaad badan ayuu tafatirayaa oo ku jira taleefanka qacanta, aqoonsiga wajiyada, la socodka mobileka iyo teknooloojiyad ayaa loo isticmaalayaa si iloola socdo dadka qaba caabuqa iyo dadka ay u dhawaadeen Koonfurta Kuuriya, Taywaan iyo Singaaboor.
If a potential risk is detected, the app not only recommends self-quarantine, it also alerts local health officials.Big data analytics on cellphone data, facial recognition technology, mobile phone tracking and artificial intelligence are used to track infected people and people whom they contacted in South Korea, Taiwan and Singapore.
Maarso 2020, dawlada Israaiil ayaa u ogolaatay hay'ada maanka inay la socoto mobile-ka dakda looga shakisan yahay inay qabaan coronavirus.
In March 2020, the Israeli government enabled security agencies to track mobile phone data of people supposed to have coronavirus.
Talaabooyin ayaa la qaaday lagu dhaqan gelinayo karantiimada iyo in la ilaaliyo dadka u dhawaaday dadka qaba caabuqa.
The measure was taken to enforce quarantine and protect those who may come into contact with infected citizens.
Sidoo kale Maarso 2020, Deutsche Telekom ayaa la wadaagtay macluumaad lagu sheegayo meesha taleefanka hay'ada dawlada federalka ee Jarmalka, Robert Koch Institute, si markaa loo baadho oo looga hortago faafitaanka fayruska.
Also in March 2020, Deutsche Telekom shared aggregated phone location data with the German federal government agency, Robert Koch Institute, in order to research and prevent the spread of the virus.
Ruushku waxa uu sameeyay teknooloojiyada lagu aqoonsanayo wajiga si loola socdo dadka jabiyay amarkoodii karantiimada.
Russia deployed facial recognition technology to detect quarantine breakers.
Gudoomiyaha caafimaadka deegaanka ee Talyaaniga Giulio Gallera waxay u sheegeen shirkada taleefanadu in "40% dadku iskaga socdaan siday doontaan."
Italian regional health commissioner Giulio Gallera said he has been informed by mobile phone operators that "40% of people are continuing to move around anyway".
Dalwada Jermalka ayaa samaysan 48 saacadood daraasad kombuyuutarka algu sameeyay labadii maalmood ee fasaxa ahaa oo ay ka qayb galeen wax ka badan 42.000 oo ruux.
German government conducted a 48 hours weekend hackathon with more than 42.000 participants.
Sidoo kale madaxweynaha Istooniyada, Kersti Kaljulaid, ayaa sameeyay baaq caalami ah oo xal loogu heleyo faafitaanka coronavirus/
Also the president of Estonia, Kersti Kaljulaid, made a global call for creative solutions against the spread of coronavirus.
Dadku way isku buuqi karaan inta ay ku jiraan karantiimada, xadidaada socdaalka, saamaynta caafimaad daro ee daawaynta ama iyaga oo ka baqanaya inay qaadaan.
Individuals may experience distress from quarantine, travel restrictions, side effects of treatment or fear of the infection itself.
BBC-yada ayaa kasoo xigatay Rory O'Connor oo leh, "Korodhka aysoleeshinka dadka, kalinimada, warwarka, isku buuqa iyo xidhitaanka dhaqaale ayaa ah dabayl waxyeelo oo caafimaadka maskaxda iyo badqabka dadka ah."
BBC quoted Rory O'Connor in saying, "Increased social isolation, loneliness, health anxiety, stress and an economic downturn are a perfect storm to harm people's mental health and wellbeing."
Waxaa dhici karta inay yareeto waxyeelada xanuunku oo calaamado yar ama aan la yeelanba, kuwaas oo u dhigma xanuunada kale ee neefsiga sida hargabka.
The disease may take a mild course with few or no symptoms, resembling other common upper respiratory diseases such as the common cold.
Xanuunada yaryar caadiga waxaa lagaga lafnaadaa laba todobaad, halka kuwa daran ama aadka u daran ay qaadan karaan ilaa lix todobaad ka ladnaanshahoodu.
Mild cases typically recover within two weeks, while those with severe or critical diseases may take three to six weeks to recover.
Dumarka uurka leh ayaa khatar badan ku jiri kara inay qaadaan COVID-19 sida lagu ogaaday macluumaadka laga heley fayrusyada lamidka ah, sida SARS iyo MERS, laakiin macluumaadka COVID-19 weli way yar yihiin. Dadka qaar, COVID-19 waxa uu saamayn karaa sababka kaas oo keenaya xanuunada sanbabka.
Pregnant women may be at higher risk for severe infection with COVID-19 based on data from other similar viruses, like SARS and MERS, but data for COVID-19 is lacking.In some people, COVID-19 may affect the lungs causing pneumonia.
Marka uu aadka u daran yahay, COVID-19 waxa uu noqon karaa xanuunka neefsiga oo aad u daran (ARDS) kaas oo keena xanuun neefsiga ah, xanuunka sumawga dhiiga oo loo miyir beelo ama unugyada oo istaaga.
In those most severely affected, COVID-19 may rapidly progress to acute respiratory distress syndrome (ARDS) causing respiratory failure, septic shock or multi-organ failure.
Mushkilada la xidhiidha COVID-19 ee sumawga dhiiga, xinjiro aan caadi ahayn iyo waxyeelada wadnaha, kalyada, iyo beerka.
Complications associated with COVID-19 include sepsis, abnormal clotting and damage to the heart, kidneys and liver.
Xinjirawga dhiiga ee aan caadiga ahayn waxa uu caadiyan kordhaa wakhtiga shaybaadhka dhiiga mudada ay qaadan kartaan xinjirawdy, waxaana la sheegey inay qabaan 6% dadka loo dhigay isbitaalka COVID-19, halka shaqada kalyada ee aan caadiga ahayn lagu arko 4% kooxdan.
Clotting abnormalities, specifically an increase in prothrombin time, have been described in 6% of those admitted to hospital with COVID-19, while abnormal kidney function is seen in 4% of this group.
Celcelis ahaan 20-30% dadka lagu arkay COVID-19 waxa ay leeyihiin enzymes beerka ah oo sare (transaminases).
Approximately 20-30% of people who present with COVID-19 demonstrate elevated liver enzymes (transaminases).
Isla warbixintaasi waxay sheegtey, wakhtiga u dhaxeeya marka calaamaduhu bilaabmaan iyo dhimashadu inay tahay toban maalmood, iyada oo shan lagu jiro isbitaalka.
According to the same report, the median time between onset of symptoms and death was ten days, with five being spent hospitalised.
Laakiin, bukaanka loo wareejiyo ICU waxa ay isku jirtaa wakhtiga u dhaxaysa marka la dhigo isbitaalka ilaa dhimashadoodu todoba maalmood.
However, patients transferred to an ICU had a median time of seven days between hospitalisation and death.
Daraasad lagu sameeyay kiisaska hore, wakhtiga la arko calaamado yar ilaa dhimashadu waa 14 maalmood, kaas oo inta ugu dheerna tahay 41 maalmood.
In a study of early cases, the median time from exhibiting initial symptoms to death was 14 days, with a full range of six to 41 days.
Daraasad ay sameeyaan Gudida Caafimaadka Qaran (NHC) ee Jayna, raga waxay leeyihiin xadi dhimasho oo ah 2.8% halka dumarkana xadigooda dhimashadu ay tahay 1.7%.
In a study by the National Health Commission (NHC) of China, men had a death rate of 2.8% while women had a death rate of 1.7%.
Shaybaadhka Histopathological ah ee muunada sanbabka ee lagu eegay waxyeeada alveolar ee fubromyxiod ee laga saaray ee sanbabka.
Histopathological examinations of post-mortem lung samples show diffuse alveolar damage with cellular fibromyxoid exudates in both lungs.
Isbadalka fayruska ayaa la badalay oo lagu arkay xanuunka sababka.
Viral cytopathic changes were observed in the pneumocytes.
Sawirka sanbabka waxaa lagu arkayay xanuunka aadka u daran ee neefsiga (ARDS).
The lung picture resembled acute respiratory distress syndrome (ARDS).
11.8% oo dhimashada ay soo sheegeen Gudida Caafimaadka Qaran ee Jayna, waxyeelada wadnaha ayaa lagu arkay inuu keeno korodhka troponin ama wadnaha oo shaqo gaba.
In 11.8% of the deaths reported by the National Health Commission of China, heart damage was noted by elevated levels of troponin or cardiac arrest.
Sida uu dhigayo macluumaadka Maarso laga heley Maraykanka, 89% oo dadka isbitaalka la dhigay waxay qabeen xanuun hore. Khayraadka dawooyinka ee la heli karo iyo dhaqan dhaqaalaha deegaan ayaa saamayn ku yeelan kara dhimashada.
According to March data from the United States, 89% of those hospitalised had preexisting conditions.Availability of medical resources and the socioeconomics of a region may also affect mortality.
Qiyaastii dhigashadu way kala duwan tahay maadaama oo ay ka jiraan xaaladuhu oo deegaanadu kala duwan yihiin, laakiin sidoo kale maadaama oo ay jirto qaabka oo adagi.
Estimates of the mortality from the condition vary because of those regional differences, but also because of methodological difficulties.
Yaraynta tirada kiisaska yaryar ee keena dhimashada waa la buun buuniyay.
The under-counting of mild cases can cause the mortality rate to be overestimated.
Laakiin, maadaama oo dhimashada uu keenay in wakhti hroe la qaaday waxay ka dhignaan karka ain xadiga dhimashada ee wakhtigan tiradeeda la yareeyay.
However, the fact that deaths are the result of cases contracted in the past can mean the current mortality rate is underestimated.
Dadka caba sigaarka waxay 1.4 jeer ay ka badan yihiin inay yeeshaan xanuuno badan oo COVID-19 ah iyo celcelis ahaan 2.4 jeer inay korodho daryeelkooda sare ama u dhintaan marka loo eego dadka aan cabin sigaarka ah. Walaac ayaa laga muujiyay xanuunka mudada dheeree xanuunkan.
Smokers were 1.4 times more likely to have severe symptoms of COVID-19 and approximately 2.4 times more likely to require intensive care or die compared to non-smokers.Concerns have been raised about long-term sequelae of the disease.
Maamulka Isbitaal Hong Kong ah ayaa ogaaday inay hoos u dhacday 20% ilaa 30% awooda sanbabka ee dadka ka ladnaaday xanuunka, oo sawir laga qaaday sanbabka waxaa lagu arkay in waxyeelo soo gaadhay unuga.
The Hong Kong Hospital Authority found a drop of 20% to 30% in lung capacity in some people who recovered from the disease, and lung scans suggested organ damage.
Tani waxay sidoo kael horseedi kartaa waxyeelo kasoo ladnaanshaha ah.
This may also lead to post-intensive care syndrome following recovery.
Ilaa Maarso 2020, laga aqoon hadii xanuun kale iyo difaaca jidhka ee mudada dheer ah ee ka ladnaaday xanuunka uu keeno caabuq.
As of March 2020, it was unknown if past infection provides effective and long-term immunity in people who recover from the disease.
In aanu waxba yeelin ayaa dhici karta, taas oo ku salaysan habdhaqanka kale ee coronavirus, laakiin kiisaska ka ladnaaday COVID-19 waxaa daba socday shaybaadh laga heley coronavirus oo markii danbe la sheegey.
Immunity is seen as likely, based on the behaviour of other coronaviruses, but cases in which recovery from COVID-19 have been followed by positive tests for coronavirus at a later date have been reported.
Kiisaskan waxaa loo arkayaa inay kasii daraan caabuqa kalka ay dib caabuq kale u noqon lahaayeen.
These cases are believed to be worsening of a lingering infection rather than re-infection.
Fayruska waxaa loo arkaa inuu yahay mid dabiici ah oo uu xayawaanka kasoo jeedo, oo uu yahay caabuq uga soo gudbay.
The virus is thought to be natural and have an animal origin, through spillover infection.
Meesha rasmiga ah ee uu ka yimid lama garanayo, laakiin Diseember 2019 faafitaanka xanuunka ayaa gebi ahaanba isku gudbinayay dadka.
The actual origin is unknown, but by December 2019 the spread of infection was almost entirely driven by human-to-human transmission.
Daraasad lagu sameeyay 41 kiis ee ugu horeeyay ee la xaqiijiyay ee COVID-19, oo lagu baahiyay Janaayo 2020, The Lancet, waxaa lagu sheegey in taariikhda hore ee ay bilaabeen calaamaduhu ahayn 1 Diseember 2019.
A study of the first 41 cases of confirmed COVID-19, published in January 2020 in The Lancet, revealed the earliest date of onset of symptoms as 1 December 2019.
Warbixin rasmi ah oo ay soo saartay WHO ayaa lagu sheegey in calaamaduhu bilaabeen 8 Diseember 2019..
Official publications from the WHO reported the earliest onset of symptoms as 8 December 2019.
Dhawr cabiraad ayaa lagu sameeyay oo caan ah oo u qalanka dhimashada ah.
Several measures are commonly used to quantify mortality.
Tirooyinkan waxa ku kala duwan deegaamada iyo mudada oo waxa ay saamayn karaa cabirka shaybaadhka, nidaamyada tayada daryeelka caafimaad, ikhtiyaarada daawaynta, wakhtiga ilaa markii uu bilaabmay iyo qaabka dakda sida da'da, jinsiga iyo caafimaadka guud.
These numbers vary by region and over time and are influenced by the volume of testing, healthcare system quality, treatment options, time since initial outbreak and population characteristics such as age, sex and overall health.
Dhamaadkii 2019, WHO waxay ku qortay ICD-10 xanuunka xeerka U07.1 ee dhimashada iyada oo laga duulayo inta uu shaybaadhku xaqiijiyay ee SARS-CoV-2 ee caabuqa ah iyo U07.2 ee dhimashada xarunta caafimaadka ama shaybaadhka xanuunada safmarka ee COVID-19 oo lagu xaqiijyay shaybaadhka caabuqa SARS-CoV-2. Xadiga dhimashada ee kiisaska waxay ay ka muuqataa tirada dhimasho oo loo qaybiyay tidada kiis ee la heley wakhti gaar ah oo cayiman.
In late 2019, WHO assigned the emergency ICD-10 disease codes U07.1 for deaths from lab-confirmed SARS-CoV-2 infection and U07.2 for deaths from clinically or epidemiologically diagnosed COVID-19 without lab-confirmed SARS-CoV-2 infection.The death-to-case ratio reflects the number of deaths divided by the number of diagnosed cases within a given time interval.
Iyada oo laga duulayo tirakoobka Jaamacada Hopkins, xadiga dhimashada kiisaska caalanku waa 6.9% (153,822/2.240,191) markii la gaadhay 17 Abriil 2020.
Based on Johns Hopkins University statistics, the global death-to-case ratio is 6.9% (153,822/2,240,191) as of 17 April 2020.
Tiradu waxaa ku kala duwanaan kara deegaamada. Talaabooyin kale oo ay ku jiraan xadiga dhimashada (CFR), taas oo ay ka muuqato tirada laga heley ee shakhsiyaad ka u dhintay xanuunka, iyo xadiga dhigasha xanuunka (IFR), kaas oo ay ka muuqato boqolkiiba inta ay yihiin shakhsiyaadka (laga baadhay ama aan la baadhin) ee u dhintay xanuunka.
The number varies by region.Other measures include the case fatality rate (CFR), which reflects the percent of diagnosed individuals who die from a disease, and the infection fatality rate (IFR), which reflects the percent of infected individuals (diagnosed and undiagnosed) who die from a disease.
Tirakoobkan waxaa dhici karta in aanu wakhti lahayn oo aanu raacin muunad gaar ah oo kiisaska ladnaaday xanuunka.
These statistics are not time bound and follow a specific population from infection through case resolution.
In kasta oo dhamaan dadku ayna wada yeelan antiboodhi, jiritaanka antiboodhiga ayaa bixin kara macluumaad ku saabsan tirada dadka ee qaaday xanuunka.
While not all infected people develop antibodies, the presence of antibodies may provide information about how many people have been infected.
Meelaha uu ku badan yahay ee Talyaaniga, Castiglione d'Adda, tuulo yar oo ilaa 4600 ku nool yihiin, 80 (1.7%) ayaa u dhintay.
In the epicentre of the outbreak in Italy, Castiglione d'Adda, a small village of 4600, 80 (1.7%) are already dead.
Galgelt, xanuunku waxa uu ku faafay munaasabad Kaarnifaal, oo waxa uu ku faafay dadka yaryar, kaas oo keenay marka loo eego tiro yar oo dhimasho, oo dhamaan dhimashada COVID-19 laguma wada sheegin inuu ka danbeeyay xanuunku.
In Gangelt, the disease was spread by Carnival festivals, and spread to younger people, causing a relatively lower mortality, and not all COVID-19 deaths may have been formally classified as such.
Sidoo kale, nidaamka caafimaadka Jermalka muu harqin.
Furthermore, the German health system has not been overwhelmed.
Needarlan, ilaa 3% ayaa yeeshay antiboodhi, sida lagu sheegey cida bixisay dhiiga.
In the Netherlands, about 3% may have antibodies, as assessed from blood donors.
69 (0.004% oo dadka ah) ayaa la xaqiijiyay inay u dhinteen COVID-19.
69 (0.004% of the population) have been confirmed to have died from COVID-19.
Saamaynta xanuunka iyo xadiga u dhimatay ayaan wax badan ayna ku kala duwananayn raga iyo dumarku.
The impact of the pandemic and its mortality rate are different for men and women.
Dhimashadu waxay ku badan tahay raga daraadan lagu sameeyay Jayna iyo Talyaaniga.
Mortality is higher in men in studies conducted in China and Italy.
Khatartu waxay kusii badan tahay raga ku jira 50yaadka, farqiga u dhaxeeya raga iyo dumarkuna ay tahay kaliya 90.
The highest risk for men is in their 50s, with the gap between men and women closing only at 90.
Jayna, xadiga dhimashada waxaa lagu sheegey 2.8 boqolkiiba inay tahay raga iyo 1.7 boqolkiiba dumarka.
In China, the death rate was 2.8 percent for men and 1.7 percent for women.
Sababta rasmiga ah ee jinsiyagu ugu kala duwan yihiin lama garanayo, laakiin hide sidaha iyo habdhaqanka ayaa noqon karan sabab keenta taas.
The exact reasons for this sex-difference is not known, but genetic and behavioural factors could be a reason.
Jinsiga oo ku salaysan kala duwanaanshaha difaaca jidhka, yaraanta cabista sigaarka ee dumarka iyo inay ragu yeeshaa xanuuno sida kacsanaan iyada oo yar marka loo eego dumarka ayaa markaa gacan ka gaysatay dhimashada badan ee raga.
Sex-based immunological differences, lesser prevalence of smoking in women and men developing co-morbid conditions such as hypertension at a younger age than women could have contributed to the higher mortality in men.
Yurub, 57% shakhsiyaadka qaaday xanuunka ee raga ah iyo 72% oo kuwaas ah ayaa u dhintay COVID-19 ayaa ahaa rag.
In Europe, 57% of the infected individuals were men and 72% of those died with COVID-19 were men.
Abriil 2020, dawlada Maraykanku lamay socon macluumadka dhimashada jinsiyada ee COVID-19.
As of April 2020, the US government is not tracking sex-related data of COVID-19 infections.
Daraasad la sameeyay ayaa muujinaya in xanuunada fayruska ee sida Ebola, HIV, hargabka iyo SARS ay si kala duwan u sameeyaan raga iyo dumarka.
Research has shown that viral illnesses like Ebola, HIV, influenza and SARS affect men and women differently.
Tirada sare ee shaqaalaha caafimaadka, gaar ahaan kaaliyayaasha caafimaadka, ayaa dumar ah, oo waxaana badan fursada ay ku qaadi karaan fayruska.
A higher percentage of health workers, particularly nurses, are women, and they have a higher chance of being exposed to the virus.
Hay'ada Caafimaadka Adduunku waxay bayaamisay 11 Febraayo 2020 in magaca rasmiga ah ee xanuunku uu yahay "COVID-19".
The World Health Organization announced on 11 February 2020 that the official name of the disease would be "COVID-19".
Madaxa WHO Tedros Adhanom Ghebreyesus ayaa sheegey in CO ay u tagan tahay corona, VI ay u taagan tahay fayrus, D ay u xaagan tahay xanuun oo 19 ay u taagan tahay markii ugu horeeyay ee safmarka la arkay: 31 Diseember 2019.
WHO chief Tedros Adhanom Ghebreyesus explained that CO stands for corona, VI for virus, D for disease, and 19 for when the outbreak was first identified: 31 December 2019.
Magaca waxaa loo doortay si la iskaga ilaaliyo in deegaan kaar ah lagu sheego xanuunka (sida Jayna), nooc xayawaan ama koox dad ah, gaas oo waafaqsan talooyinka caalami ee ujeedada magaga si loo baajiyo takoor. Fayruska keena COVID-19 waxaa weeye magiciisu coronaviruska xanuunka neefsiga ee daran 2 (SARS-CoV-2).
The name had been chosen to avoid references to a specific geographical location (e.g. China), animal species or group of people, in line with international recommendations for naming aimed at preventing stigmatisation.The virus that causes COVID-19 is named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
WHO waxay sidoo kale isticmaashaa "fayruska COVID-19" iyo "fayruska keena COVID-19" marka ay warbixinaha soo saarayso.
The WHO additionally uses "the COVID-19 virus" and "the virus responsible for COVID-19" in public communications.
Xanuunka iyo fayruska labadaba waxaa loo yaqaan "coronavirus".
Both the disease and virus are commonly referred to as "coronavirus".
Intii lagu jiray safmarka hore ee Wuhan, Jayna, fayruska iyo xanuuna waxaa loo yaqaanay "coronavirus" iyo "Wuhan coronavirus".
During the initial outbreak in Wuhan, China, the virus and disease were commonly referred to as "coronavirus" and "Wuhan coronavirus".
Janaayo 2020, WHO waxay ku talinaysay in 2019-nCov iyo 2019 nCoV xanuunka daran ee neefsiga uu noqdo magac ku meel gaadh ah oo fayruska ah iyo xanuunka si waafaqsan tilmaamaha 2015 ee in aan la isticmaalin ah meel marka la magacaabayo xanuun iyo fayrus.
In January 2020, WHO recommended 2019-nCov and 2019-nCoV acute respiratory disease as interim names for the virus and disease in accordance with 2015 guidance against using locations in disease and virus names.
Magaca rasmiga ah ee COVID-19 iyo SARS-CoV-2 waxaa la sameeyay 11 Febraayo 2020.
The official names COVID-19 and SARS-CoV-2 were issued on 11 February 2020.
Maadaama oo ay jirtey xadidaad heerka iibka, warshadaha qaar dhijitaal ah ayaa daabacay waxyaabaha daryeelka caafimaad sida buushka lagu qaado muunada duufka iyo qaybaha uu ka kooban yahay qalabka neefsigu.
Due to capacity limitations in the standard supply chains, some digital manufacturers are printing healthcare material such as nasal swabs and ventilator parts.
Tusaale ahaan, marka isbitaalka Talyaanigu uu si dhakhso ah u dalbaday qababadaha mishiinka neefsiga, oo lana waayay agabkii wakhtigaa loo baahnaa, shirkad bilaw ah oo deegaan ah ayaa samaysay oo daabacday 100 qasabood habeen kaliya.
In one example, when an Italian hospital urgently required a ventilator valve, and the supplier was unable to deliver in the timescale required, a local startup reverse-engineered and printed the required 100 valves overnight.
Kadib markii uu soo baxay safmarkii COVID-19 ugu horeeyay, waxyaabo badan ayaa la iska dhax marayay, macluumaad khaldan iyo macluumaad been ah oo ah meesha uu ka yimid, inta uu le'eg yahay, kahortaga, daawaynta iyo dhinacyo kale oo xanuunka ah oo markaa si dhakhso ah ugu baahan online ahaan.
After the initial outbreak of COVID-19, conspiracy theories, misinformation and disinformation emerged regarding the origin, scale, prevention, treatment and other aspects of the disease and rapidly spread online.
Bilaa aadanka ayaad moodaa ainay awood u leeyihiin marka loo eego xayawaanada kale qaar.
Humans appear to be capable of spreading the virus to some other animals.
Daraadaha ayaan lagu ogaanin inuu yahay fayruska ka yimid doofaarka, xuurbadeeda, iyo digaaga.
The study failed to find evidence of viral replication in pigs, ducks, and chickens.
Ma laha dawo ama talaal la ansixiyay oo lagu daweeyo.
No medications or vaccine is approved to treat the disease.
Daraasado caalami ah ayaa socda oo talaalka iyo dawooyinka COVID-19 ah oo ay wadaan hay'ado iyo dawladu, kooxda waxbarasho iyo waaxaha daraasada.
International research on vaccines and medicines in COVID-19 are underway by government organisations, academic groups and industry researchers.
Maarso, Hay'ada Caafimaadka Adduunka ayaa bilawday "Tijaabo WAJIR AH" oo lagu qiimaynayo wax ku oolnimada daawayn amar dawo oo fayrusyada ah oo markaa la sheegey inay waxtari karaan.
In March, the World Health Organization initiated the "SOLIDARITY Trial" to assess treatment effects of four existing antiviral compounds with the most promise of efficacy.
Malaha talaal, laakiin hay'ado kala duwan ayaa ka shaqaynaya sidii talaal loogu geli lahaa.
There is no available vaccine, but various agencies are actively developing vaccine candidates.
Shaqooyinka hore ee SARS-CoV ayaa laga faa'ideeyay maadaama oo SARS-CoV iyo SARS-CoV-2 labadaha loo isticmaalo qaadaha ACE2 oo gala unugada bilaa aadanka.
Previous work on SARS-CoV is being utilised because SARS-CoV and SARS-CoV-2 both use the ACE2 receptor to enter human cells.
Waxaa jira sadex marxaladood oo talaalka ah oo la baadhayo.
There are three vaccination strategies being investigated.
Ta kowaad, cilmi baadhayaasha ayay tahay ujeedadoodu inay sameeyaan talaal fayruska ah oo dhan.
First, researchers aim to build a whole virus vaccine.
Isticmaalka fayruska noocan ah, oo aan firfircoonayn ama dhintay, waxaa loogu talo geley in jawaabta difaaca jidhka lagu carbiyo ee jidhka bilaa aadanka caabuqa cusub ee COVID-19.
The use of such a virus, be it inactive or dead, aims to elicit a prompt immune response of the human body to a new infection with COVID-19.
Khidada labaad, lasoo baxa talaalka, waxaa lagu doonayaa in lagu ogaado xasaasinimada nidaamka difaaca ee fayrusyada qaar lala soco baxay.
A second strategy, subunit vaccines, aims to create a vaccine that sensitises the immune system to certain subunits of the virus.
Marka la eego SARS-CoV-2, daraasadaha noocan ah waxaa diirada lagu saarayaa korodhka-S ee borootiinta ee ka caawinaysa fayruska qaadaha enzyme ACE2.
In the case of SARS-CoV-2, such research focuses on the S-spike protein that helps the virus intrude the ACE2 enzyme receptor.
Khidada sadexaad ee talaalka aysiidha nukuleeska (talaalka DNA ama RNA, farsamada novel ee lagu samaynayo talaalka).
A third strategy is that of the nucleic acid vaccines (DNA or RNA vaccines, a novel technique for creating a vaccination).
Talaal tijaabo ah oo lagu sameeyay khidada wax ka mid ayaa la tijaabin doonaa amaanka iyo wax ku oolkiisa. 16 Maarso 2020, tijaabadii ugu horeysay ee caafimaadka ee talaalka ayaa ku bilaabantay afar ruux oo iskood u ogolaaday Seattle.
Experimental vaccines from any of these strategies would have to be tested for safety and efficacy.On 16 March 2020, the first clinical trial of a vaccine started with four volunteers in Seattle.
Talaalka waxaa ku jira nuqul hide side ah oo aan waxyeelo alahyn oo fayruska keena ah xanuunka. Waxaa kordhaysa antiboodhiga taas oo sheegeysa inay jirto caqabad talaalka samayntiisa ah ee SARS-COV-2, laakiin waa la isku khilaafsan yahay.
The vaccine contains a harmless genetic code copied from the virus that causes the disease.Antibody dependent enhancement has been suggested as a potential challenge for vaccine development for SARS-COV-2, but this is controversial.
Waxaa jira wax ka badan 300 oo tijaabo caafimaad ah oo shaqaynaya oo socda ilaa Abriil 2020.
There are more than 300 active clinical trials underway as of April 2020.
Dhawr tijaabo ayaa la qiimeeyay oo hore loogu ansixiyay malaatiyada, oo ay kujiraan daraasadaha hydroxychloroquine ama chloroquine.
Seven trials were evaluating already approved treatments for malaria, including four studies on hydroxychloroquine or chloroquine.
Dib u isticmaalka dawooyinka fayruska ayuu ahaa daraasada Jayniisku, taas oo maratay sagaal wajiga iii ee tijaabada ee remdesivir ee dhawr dal warbixin la soo saaray dhamaadkii Abriil siday sheegeysay.